Challenges in Drug Development

Considerable challenges in drug development, particularly in the face of further organizational changes slated for OGD. A range of legislative and regulatory actions have facilitated consumer access to safe, high-quality generic products, although manufacturing lapses and product quality problems have created critical shortages in important medicines, casting a shadow over the industry's success.

 

  • Phase zero trials
  • Mechanism
  • Drug delivery essentials towards better bioavailability

Related Conference of Challenges in Drug Development

March 23-24, 2020

World Congress on Biosensors and Bioelectronics

Osaka, Japan
April 16-17, 2020

16th World Congress on Structural Biology

Amsterdam, Netherlands
April 20-21, 2020

11th Tissue Science and Regeneration Congress

Kualalumpur, Malaysia
June 28-30 2020

globalbiotechnology-cs-2020

June 28-30 2020

oilgas-cs-2020

June 28-30 2020

BEHAVIOURAL SCIENCE-2020

June 28-30 2020

Bioinfo 2020

May 10-11, 2020

26th World Nursing & Nurse Practitioner Conference

Yokohama, Japan
July 17-18, 2020

10th Glycobiology World Congress

Vienna, Austria
August 4-5, 2020

12th Euro Biosensors & Bioelectronics Congress

Zurich, Switzerland
September 28-29, 2020

2nd International Conference on Metabolomics, Genomics and Proteomics

Singapore City, Singapore
September 28-29, 2020

19th International Conference on Structural Biology

Barcelona, Spain
October 08-09, 2020

10th European Biosimilars Summit

Milan, Italy
October 14-15, 2020

9th World Congress on Glycobiology & Glycochemistry

Rome, Italy

Challenges in Drug Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in